The Liver Meeting 2020-Nonalcoholic Fatty Liver Disease SIG Clinical Management of NASH in 2020

Nonalcoholic Fatty Liver Disease SIG Clinical Management of NASH in 2020

Video Transcription

Video Summary

The video provides an overview of the clinical management of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in 2020. It discusses the importance of lifestyle modifications, potential use of medications and surgery, and targeting the root cause of the disease. Emphasis is placed on improving disease activity to prevent progression and eventually improve fibrosis. The debate on whether to target NASH resolution or fibrosis improvement as treatment endpoints is explored. The transcript also covers the role of non-invasive tests, advancements in liver biopsy interpretation, and the development of therapeutics for NAFLD and NASH. Lastly, it highlights the challenges and advancements in managing these diseases, along with future research and treatment strategies.

Keywords

clinical management

NAFLD

NASH

lifestyle modifications

medications

surgery

disease activity

fibrosis

NASH resolution

non-invasive tests

liver biopsy

therapeutics

treatment strategies